share_log
Reuters ·  04:48

Novo Nordisk Shares Extend Losses, Now Down 19%, on Track for Worst Day Since April 2002. Eli Lilly Shares up 7.6% Premarket After Novo Nordisk's Cagrisema Achieves Lower-Than-Expected Weight Loss in Trial

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment